Streetbeat News

Price Targets

ATSG

Susquehanna analyst Christopher Stathoulopoulos maintains a positive outlook on Air Transport Services Group (ATSG) and raises the price target from $18 to $26.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 5:08 pm

VRDN

JMP Securities analyst Jason Butler maintains a Market Outperform rating on Viridian Therapeutics (NASDAQ:VRDN) but lowers the price target from $44 to $42.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 5:07 pm

SKWD

JMP Securities analyst Matthew Carletti maintains a Market Outperform rating on Skyward Specialty (NASDAQ:SKWD) and raises the price target from $30 to $32.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 5:06 pm

OB

JMP Securities analyst Andrew Boone maintains a Market Outperform rating on Outbrain (NASDAQ:OB) and raises the price target from $6 to $8.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 5:05 pm

LPRO

JMP Securities analyst David Scharf has maintained a Market Outperform rating on Open Lending (NASDAQ:LPRO), but lowered the price target from $12 to $11.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 5:04 pm

HIPO

JMP Securities analyst Matthew Carletti maintains a Market Outperform rating on Hippo Holdings (NYSE:HIPO) but has lowered the price target from $70 to $50.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 5:04 pm

CRNX

JMP Securities analyst Jonathan Wolleben maintains a Market Outperform rating on Crinetics Pharmaceuticals (NASDAQ:CRNX) but lowers the price target from $43 to $42.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 5:02 pm

ENR

In the last quarter, Energizer Hldgs (NYSE:ENR) received 2 somewhat bullish and 2 indifferent ratings from analysts. The company's average 12-month price target is $37.0, representing a 4.52% decrease from the previous average price target of $38.75.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 5:02 pm

BL

JMP Securities analyst Patrick Walravens maintains a Market Outperform rating on BlackLine (NASDAQ:BL) but lowers the price target from $87 to $81.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 5:01 pm

KPRX

Maxim Group analyst Michael Okunewitch maintains a 'Buy' rating on Kiora Pharmaceuticals (NASDAQ:KPRX), but has lowered the price target from $12 to $2.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 09, 2023 | 5:01 pm